These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 37150674)

  • 1. Cardiovascular health and target end-organ damage and comorbidities in hypertensive patients from a Spanish primary care urban population.
    Armas-Padrón AM; Sicilia-Sosvilla M; Ruiz-Esteban P; Torres A; Hernández D
    Nefrologia (Engl Ed); 2024; 44(1):77-89. PubMed ID: 37150674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between Cardiovascular Health, C-Reactive Protein, and Comorbidities in Spanish Urban-Dwelling Overweight/Obese Hypertensive Patients.
    Armas-Padrón AM; Sicilia-Sosvilla M; Ruiz-Esteban P; Torres A; Hernández D
    J Cardiovasc Dev Dis; 2023 Jul; 10(7):. PubMed ID: 37504556
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal ankle-brachial index, cardiovascular risk factors and healthy lifestyle factors in hypertensive patients: prospective cohort study from a primary care urban population.
    Armas-Padrón AM; Sicilia-Sosvilla M; Rodríguez-Bello S; López-Carmona MD; Ruiz-Esteban P; Hernández D
    BMC Prim Care; 2022 Sep; 23(1):232. PubMed ID: 36085011
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypertension-Mediated Organ Damage and Long-term Cardiovascular Outcomes in Asian Hypertensive Patients without Prior Cardiovascular Disease.
    Oh JS; Lee CH; Park JI; Park HK; Hwang JK
    J Korean Med Sci; 2020 Dec; 35(48):e400. PubMed ID: 33316856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence, impact and management of hypertension-mediated organ damage in type 2 diabetes patients.
    Romero-Secin AA; Díez-Espino J; Prieto-Díaz MA; Pallares-Carratala V; Barquilla-García A; Micó-Pérez RM; Polo-García J; Velilla-Zancada SM; Martín-Sanchez V; Segura-Fragoso A; Ginel-Mendoza L; Arce-Vazquez VM; Cinza-Sanjurjo S
    Semergen; 2024 Mar; 50(6):102220. PubMed ID: 38554607
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypertension-Mediated Organ Damage: Prevalence, Correlates, and Prognosis in the Community.
    Vasan RS; Song RJ; Xanthakis V; Beiser A; DeCarli C; Mitchell GF; Seshadri S
    Hypertension; 2022 Mar; 79(3):505-515. PubMed ID: 35138872
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypertension mediated kidney and cardiovascular damage and risk stratification: Redefining concepts.
    Márquez DF; Rodríguez-Sánchez E; de la Morena JS; Ruilope LM; Ruiz-Hurtado G
    Nefrologia (Engl Ed); 2022; 42(5):519-530. PubMed ID: 36792306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypertensive emergencies and urgencies: a preliminary report of the ongoing Italian multicentric study ERIDANO.
    Vallelonga F; Cesareo M; Menon L; Leone D; Lupia E; Morello F; Totaro S; Aggiusti C; Salvetti M; Ioverno A; Maloberti A; Fucile I; Cipollini F; Nesti N; Mancusi C; Pende A; Giannattasio C; Muiesan ML; Milan A
    Hypertens Res; 2023 Jun; 46(6):1570-1581. PubMed ID: 36805031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel biomarkers in patients with uncontrolled hypertension with and without kidney damage.
    Brobak KM; Halvorsen LV; Aass HCD; Søraas CL; Aune A; Olsen E; Bergland OU; Rognstad S; Blom KB; Birkeland JAK; Høieggen A; Larstorp ACK; Solbu MD
    Blood Press; 2024 Dec; 33(1):2323980. PubMed ID: 38606688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypertension-mediated organ damage involving multiple sites is an independent risk factor for cardiovascular events.
    Lembo M; Pacella D; Manzi MV; Morisco C; La Mura L; Mancusi C; Bardi L; Trimarco V; Trimarco B; Izzo R; Esposito G
    Eur Heart J Open; 2023 Sep; 3(5):oead102. PubMed ID: 37881599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypertension-mediated organ damage and established cardiovascular disease in patients with hypertension: the China Hypertension Survey, 2012-2015.
    Wang X; Hao G; Chen L; Yang Y; Zhou H; Kang Y; Shaver L; Chen Z; Zheng C; Zhang L; Li S; Wang Z; Gao R
    J Hum Hypertens; 2022 Dec; 36(12):1092-1098. PubMed ID: 34799686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypertension-Mediated Organ Damage In Young Patients With First-Diagnosed And Never Treated Systolic Hypertension.
    Benas D; Triantafyllidi H; Birmpa D; Fambri A; Schoinas A; Thymis I; Kostelli G; Ikonomidis I
    Curr Vasc Pharmacol; 2023; 21(3):197-204. PubMed ID: 37533181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations of Walking Activity With Hypertensive Mediated Organ Damage in Community-Dwelling Elderly Chinese: The Northern Shanghai Study.
    Lyu Y; Yu S; Chi C; Teliewubai J; Li J; Blacher J; Pu J; Zhang Y; Xu Y
    Front Cardiovasc Med; 2021; 8():734766. PubMed ID: 34746252
    [No Abstract]   [Full Text] [Related]  

  • 14. Predictive Performance of Triglyceride-Glucose Index on Asymptomatic Multiple Organ Damage in Patients with Newly Diagnosed Hypertension.
    Kivrak A; Yildirim A
    Rev Invest Clin; 2023; 75(5):221-232. PubMed ID: 37918012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High prevalence of hypertension and target organ damage in patients with 11β-hydroxylase deficiency.
    Sun B; Lu L; Gao Y; Yu B; Chen S; Tong A; Wu X; Mao J; Wang X; Zhao Z; Zhang W; Nie M
    Clin Endocrinol (Oxf); 2022 May; 96(5):657-665. PubMed ID: 35067946
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Characteristics and cardiovascular events in a general population included in the RICARTO (RIesgo CARdiovascular TOledo) study: Data from the first 1,500 individuals included in the study].
    Rodríguez-Roca GC; Segura-Fragoso A; Villarín-Castro A; Alonso-Moreno FJ; Rodríguez-Padial L; Rodríguez-García ML; Fernández-Conde JA; Rojas-Martelo GA; Menchén-Herreros A; Escobar-Cervantes C; Fernández-Martín J; Artigao-Rodenas LM; Carbayo-Herencia JA; Hernández-Moreno J;
    Semergen; 2018 Apr; 44(3):180-191. PubMed ID: 28869129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of hypertension-mediated organ damage in children and adolescents with hypertension.
    Pac M; Obrycki Ł; Koziej J; Skoczyński K; Starnawska-Bojsza A; Litwin M
    Blood Press; 2023 Dec; 32(1):2212085. PubMed ID: 37259507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of ideal cardiovascular health metrics and incident type 2 diabetes mellitus among an urban population of Iran: One decade follow up in the Tehran Lipid and Glucose Study.
    Asgari S; Masrouri S; Hosseinpour-Niazi S; Moslehi N; Azizi F; Hadaegh F
    J Diabetes Investig; 2022 Oct; 13(10):1711-1722. PubMed ID: 35588067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subclinical Hypertension-Mediated Organ Damage (HMOD) in Hypertension: Atherosclerotic Cardiovascular Disease (ASCVD) and Calcium Score.
    Rizzoni D; Agabiti-Rosei C; De Ciuceis C; Boari GEM
    High Blood Press Cardiovasc Prev; 2023 Jan; 30(1):17-27. PubMed ID: 36376777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fatty liver index and hypertension-mediated organ damage in never-treated hypertensive patients without diabetes mellitus.
    Siafi E; Andrikou I; Konstantinidis D; Kakouri N; Iliakis P; Koskinas J; Koullias E; Thireos E; Tousoulis D; Thomopoulos C; Tsioufis C
    J Hypertens; 2021 Dec; 39(12):2470-2477. PubMed ID: 34738990
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.